Dwayne Henry, MD
Sleep Medicine · Baton Rouge, LANPI 1952359077
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,408 of the $5,790 with a category attached, or 76.1%. 17 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 36.8% of the total. 2025 is the largest year on record at $2,530, 3.5 times the $726 reported in 2019.
Across 137 payments — averaging $42.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$2K
- Inspire Medical Systems, Inc.$2K
- Harmony Biosciences LLC$990
- Itamar Medical Inc$147
- Eisai Inc.$125
- GSK$123
- plus $427 from 11 others
What the payments were for
- Consulting fees$1503%
- Travel & lodging$87515%
- Food & beverage$4,40876%
- Education$3356%
- Entertainment$220%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 60 | $2,133 |
| Inspire Medical Systems, Inc. | 17 | $1,845 |
| Harmony Biosciences LLC | 29 | $990 |
| Itamar Medical Inc | 4 | $147 |
| Eisai Inc. | 1 | $125 |
| GSK | 1 | $123 |
| Axsome Therapeutics, Inc. | 8 | $111 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $55 |
| Travere Therapeutics, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $42 |
| Cumberland Pharmaceuticals, Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $31 |
| Idorsia Pharmaceuticals US Inc | 2 | $26 |
| Arbor Pharmaceuticals, Inc. | 2 | $24 |
| CSL Behring | 1 | $21 |
| Sobi, Inc | 1 | $18 |
| Shire North American Group Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,790 in reported general payments places this provider in the 75th percentile of 20 sleep medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $647 |
| Modafinil | 12 | $477 |
| Zolpidem Tartrate ErZolpidem Tartrate | 14 | $451 |
| Doxepin Hcl | 13 | $89 |
| Trazodone Hcl | 14 | $42 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Baton Rouge
- Matthew AbrahamLafayette$23K
- Sara MunjampalliShreveport$19K
- Oleg ChernyshevShreveport$15K
- Joseph BordelonOpelousas$8K
- Brittany MonceauxShreveport$4K
- Lauren DavisCovington$4K
- Liudmila LysenkoNew Orleans$3K
- Clinton YoungLafayette$3K
- Naomi GhildiyalShreveport$3K
- Abigail BoudreauxNew Orleans$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.